The present invention relates to 5,8-Dimethyl-2-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine hemiadipate, which is non-hygroscopic. The present invention also relates to pharmaceutical compositions comprising 5,8-Dimethyl-2-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine hemiadipate, as well as the use of 5,8-Dimethyl-2-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine hemiadipate in therapy. The 5,8-Dimethyl-2-[2-(1-methyl-4-phenyl-1H-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine hemiadipate being depicted below.
本发明涉及5,8-二甲基-2-[2-(1-甲基-4-苯基-
1H-咪唑-2-基)-乙基]-[1,2,4]三唑并[1,5-a]
吡嗪半
己二酸盐,该化合物不吸湿。本发明还涉及含有5,8-二甲基-2-[2-(1-甲基-4-苯基-
1H-咪唑-2-基)-乙基]-[1,2,4]三唑并[1,5-a]
吡嗪半
己二酸盐的药物组合物,以及在治疗中使用5,8-二甲基-2-[2-(1-甲基-4-苯基-
1H-咪唑-2-基)-乙基]-[1,2,4]三唑并[1,5-a]
吡嗪半
己二酸盐。下面展示了5,8-二甲基-2-[2-(1-甲基-4-苯基-
1H-咪唑-2-基)-乙基]-[1,2,4]三唑并[1,5-a]
吡嗪半
己二酸盐的结构。